Evidence map›Paper›PMID 31729414›Full record

ArticleScientific reports2019

CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network.

Kanggeun Lee, Hyoung-Oh Jeong, Semin Lee, Won-Ki Jeong

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. AI based multiomics integration for cancer diagnosis and prognosis.Journal, genetic engineering & biotechnology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble.Computational and mathematical methods in medicine · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kanggeun LeeSchool of Electrical and Computer Engineering, UNIST, Ulsan, Republic of Korea.
Hyoung-Oh JeongDepartment of Biomedical Engineering, School of Life Sciences, UNIST, Ulsan, Republic of Korea.
Semin LeeDepartment of Biomedical Engineering, School of Life Sciences, UNIST, Ulsan, Republic of Korea. seminlee@unist.ac.kr.ORCID http://orcid.org/0000-0002-9015-6046
Won-Ki JeongSchool of Electrical and Computer Engineering, UNIST, Ulsan, Republic of Korea. wkjeong@unist.ac.kr.ORCID http://orcid.org/0000-0002-9393-6451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With recent advances in DNA sequencing technologies, fast acquisition of large-scale genomic data has become commonplace. For cancer studies, in particular, there is an increasing need for the classification of cancer type based on somatic alterations detected from sequencing analyses. However, the ever-increasing size and complexity of the data make the classification task extremely challenging. In this study, we evaluate the contributions of various input features, such as mutation profiles, mutation rates, mutation spectra and signatures, and somatic copy number alterations that can be derived from genomic data, and further utilize them for accurate cancer type classification. We introduce a novel ensemble of machine learning classifiers, called CPEM (Cancer Predictor using an Ensemble Model), which is tested on 7,002 samples representing over 31 different cancer types collected from The Cancer Genome Atlas (TCGA) database. We first systematically examined the impact of the input features. Features known to be associated with specific cancers had relatively high importance in our initial prediction model. We further investigated various machine learning classifiers and feature selection methods to derive the ensemble-based cancer type prediction model achieving up to 84% classification accuracy in the nested 10-fold cross-validation. Finally, we narrowed down the target cancers to the six most common types and achieved up to 94% accuracy.

Indexed as

Genetic TestingGenetic VariationMachine LearningNeural Networks, ComputerAlgorithmsDatabases, FactualGenomicsHumansLinear ModelsMutationNeoplasmsReproducibility of ResultsWorkflow

Identifiers

PMID31729414
PMCPMC6858312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.